- 全部删除
您的购物车当前为空
UNBS5162 (UNBS-5162) 是一种新型萘酰亚胺,可降低实验性前列腺癌中 CXCL 趋化因子的表达。它是一种广谱趋化因子配体CXCL 拮抗剂,具有抗肿瘤活性。


为众多的药物研发团队赋能,
让新药发现更简单!
UNBS5162 (UNBS-5162) 是一种新型萘酰亚胺,可降低实验性前列腺癌中 CXCL 趋化因子的表达。它是一种广谱趋化因子配体CXCL 拮抗剂,具有抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 327 | In stock | |
| 5 mg | ¥ 775 | 待询 | |
| 10 mg | ¥ 1,230 | 待询 | |
| 25 mg | ¥ 2,230 | 待询 | |
| 50 mg | ¥ 3,360 | 待询 | |
| 100 mg | ¥ 4,780 | 待询 | |
| 200 mg | ¥ 6,660 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 877 | In stock |
UNBS5162 相关产品
| 产品描述 | UNBS5162 (UNBS-5162) is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. |
| 别名 | UNBS-5162, UNBS 5162 |
| 分子量 | 326.35 |
| 分子式 | C17H18N4O3 |
| CAS No. | 956590-23-1 |
| Smiles | CN(C)CCN1C(=O)c2cccc3cc(NC(N)=O)cc(C1=O)c23 |
| 密度 | 1.389 g/cm3 (Predicted) |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 11 mg/mL (33.71 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容